Riskpilot← Back to searchSign inGet full accessMigränkliniken Europa AB
ABActiveOrg 5569229783Rydgatan 1Day spa, sauna and steam bath activities · NACE 9623Est. 20130 employees
Revenue 2025
SEK 2,5M
+6% vs 2024
EBITDA margin
75.6%
0% vs 2024
Equity ratio
82.8%
Financial strength
Net profit 2025
SEK 567K
-18% vs 2024
| Revenue | SEK 2,5M | +6% |
| EBITDA | SEK 1,9M | +0% |
| Net profit | SEK 567K | -18% |
| Total assets | SEK 4,9M | +11% |
| Equity | SEK 4,1M | +16% |
| Employees | 0 | — |
Legal name
Migränkliniken Europa AB
Org number
5569229783
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
18 februari 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är bedrivande av vård och behandling av patienter med migrän och likande svår huvudvärks- problematik och därmed förenlig verksamhet.
Address
Rydgatan 1
Phone
+4637012980
Email
monicha@migrankliniken.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 636 | 2 012 | 2 311 | 2 360 | 2 506 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 259 | 1 565 | 1 806 | 1 890 | 1 894 |
| Depreciation & amort. | −59 | −78 | −56 | −26 | −26 |
| EBIT | 1 200 | 1 487 | 1 750 | 1 864 | 1 868 |
| Net financials | — | 9 | — | — | 123 |
| Profit before tax | 425 | 597 | 974 | 873 | 715 |
| Tax | −91 | −123 | −201 | −180 | −148 |
| Net profit | 334 | 474 | 773 | 693 | 567 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 519 | 2 940 | 3 570 | 4 427 | 4 902 |
| Equity | 1 550 | 2 023 | 2 796 | 3 490 | 4 057 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 940 | 878 | 758 | 925 | 831 |
| Total debt | 940 | 878 | 758 | 925 | 831 |
EBITDA margin
75.6%
This company
15.8%
Market median
+378% vs market
20212025
Equity ratio
82.8%
This company
38.2%
Market median
+117% vs market
20212025
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
20212025
Net profit margin
22.6%
This company
8.1%
Market median
+179% vs market
20212025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MF Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Konsulthälsan, Södra Sverige Aktiebolag
Migränkliniken Europa AB Board members of Migränkliniken Europa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monicha Freja Norén | Chief Executive Officer | 0 companies |
| Emma Catharina Josefine Orrgard | Deputy Board Member | 0 companies |
| Kajsa Freja Lisa Norén | Deputy Board Member | 0 companies |
| Oscar David Åke Norén | Deputy Board Member | 0 companies |